With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
As a revised version of the US Bioshield II Bill is expected to be published soon, an informal coalition of global health advocates groups has laid out some principles which they have agreed by which legislation should be judged.
The groups that have endorsed this position are: Aeras Global TB Vaccine Foundation, AIDS Vaccine Advocacy Coalition, Albert B. Sabin Vaccine Institute, Alliance for Microbicide Development, American Society of Tropical Medicine and Hygiene, BIO Ventures for Global Health, International AIDS Vaccine Initiative, International Partnership for Microbicides, Medicines for Malaria Venture, PATH
CGD blog posts reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions.